![[up]](/style/images/multi_up.png)
Up a levelGroup by: Item Type | Date
Jump to: Journal article
Number of items: 15.
Journal article
Burchert, Andreas 
ORCID: https://orcid.org/0000-0002-8411-8844; Nicolini, Franck E.; Coutre, Philipp le; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834; Tuere, Evin; Metzelder, Stephan K.; Pauck, Kim; Garn, Holger; Raifer, Hartmann; Huber, Magdalena ORCID: https://orcid.org/0000-0002-2963-0693; Gattermann, Norbert; Crysandt, Martina; Schafhausen, Philippe; Bormann, Matthias; Radsak, Markus P. ORCID: https://orcid.org/0000-0002-3991-5721; Guerci-Bresler, Agnès; Illmer, Thomas; Goebeler, Maria E.; Herhaus, Peter; Teichmann, Lino L.; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Lang, Fabian; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Möhle, Robert; Klausmann, Martine; Stegelmann, Frank ORCID: https://orcid.org/0000-0003-2157-476X; Lutz, Christoph; Etienne, Gabriel; Stoltefuß, Andrea; Göthert, Joachim R.; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Abu-Samra, Maisun; Höffkes, Heinz-Gert; Neubauer, Andreas ORCID: https://orcid.org/0000-0002-7606-8760; Wang, Ying; Weiland, Paul ORCID: https://orcid.org/0000-0003-3175-8271; Otto, Clara; Kiessler, Lea; Weber, Theresa; Kroning, Lea; Nist, Andrea; Stiewe, Thorsten ORCID: https://orcid.org/0000-0003-0134-7826; Hehlmann, Rüdiger; Aminossadati, Behnaz; Wittenberg, Michael ORCID: https://orcid.org/0000-0003-4526-1856; Winterstein, Kerstin; Oellerich, Thomas ORCID: https://orcid.org/0000-0001-6570-6125; Lechner, Marcus; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Schade-Brittinger, Carmen; Klemm, Paul ORCID: https://orcid.org/0000-0002-3609-5713 und Michel, Christian
(2026):
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).
In: Leukemia, Vol. 40: pp. 410-417
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-8411-8844; Nicolini, Franck E.; Coutre, Philipp le; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834; Tuere, Evin; Metzelder, Stephan K.; Pauck, Kim; Garn, Holger; Raifer, Hartmann; Huber, Magdalena ORCID: https://orcid.org/0000-0002-2963-0693; Gattermann, Norbert; Crysandt, Martina; Schafhausen, Philippe; Bormann, Matthias; Radsak, Markus P. ORCID: https://orcid.org/0000-0002-3991-5721; Guerci-Bresler, Agnès; Illmer, Thomas; Goebeler, Maria E.; Herhaus, Peter; Teichmann, Lino L.; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Lang, Fabian; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Möhle, Robert; Klausmann, Martine; Stegelmann, Frank ORCID: https://orcid.org/0000-0003-2157-476X; Lutz, Christoph; Etienne, Gabriel; Stoltefuß, Andrea; Göthert, Joachim R.; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Abu-Samra, Maisun; Höffkes, Heinz-Gert; Neubauer, Andreas ORCID: https://orcid.org/0000-0002-7606-8760; Wang, Ying; Weiland, Paul ORCID: https://orcid.org/0000-0003-3175-8271; Otto, Clara; Kiessler, Lea; Weber, Theresa; Kroning, Lea; Nist, Andrea; Stiewe, Thorsten ORCID: https://orcid.org/0000-0003-0134-7826; Hehlmann, Rüdiger; Aminossadati, Behnaz; Wittenberg, Michael ORCID: https://orcid.org/0000-0003-4526-1856; Winterstein, Kerstin; Oellerich, Thomas ORCID: https://orcid.org/0000-0001-6570-6125; Lechner, Marcus; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Schade-Brittinger, Carmen; Klemm, Paul ORCID: https://orcid.org/0000-0002-3609-5713 und Michel, Christian
(2026):
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).
In: Leukemia, Vol. 40: pp. 410-417
[PDF, 1MB]
Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana ORCID: https://orcid.org/0009-0000-5020-7040; Yakoleva, Julia; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Milojkovic, Dragana; Fabisch, Christian; Nicolini, Franck E.; Olsson-Stromberg, Ulla; Zackova, Daniela; Lewandowski, Krzysztof; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Zupan, Irena; Voskanyan, Astghik; Gołos, Aleksandra; Frietsch, Jochen J. ORCID: https://orcid.org/0000-0002-1476-8059; Gil, Justyna; Faber, Edgar ORCID: https://orcid.org/0000-0002-3259-7791; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Parry, Anne; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Heibl, Sonja; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Casado, Luis Felipe; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Eder, Matthias; Anhut, Peter; Trautmann-Grill, Karolin ORCID: https://orcid.org/0000-0002-9050-1049; Szczepanek, Elzbieta; Südhoff, Thomas; Patkowska, Elzbieta; Kiani, Alexander; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Apperley, Jane ORCID: https://orcid.org/0000-0002-1710-1794; Mayer, Jiri; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690 und Brioli, Annamaria ORCID: https://orcid.org/0000-0002-4072-7592
(2026):
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.
In: Leukemia, Vol. 40: pp. 751-758
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6662-7127; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana ORCID: https://orcid.org/0009-0000-5020-7040; Yakoleva, Julia; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Milojkovic, Dragana; Fabisch, Christian; Nicolini, Franck E.; Olsson-Stromberg, Ulla; Zackova, Daniela; Lewandowski, Krzysztof; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Zupan, Irena; Voskanyan, Astghik; Gołos, Aleksandra; Frietsch, Jochen J. ORCID: https://orcid.org/0000-0002-1476-8059; Gil, Justyna; Faber, Edgar ORCID: https://orcid.org/0000-0002-3259-7791; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Parry, Anne; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Heibl, Sonja; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Casado, Luis Felipe; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Eder, Matthias; Anhut, Peter; Trautmann-Grill, Karolin ORCID: https://orcid.org/0000-0002-9050-1049; Szczepanek, Elzbieta; Südhoff, Thomas; Patkowska, Elzbieta; Kiani, Alexander; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Apperley, Jane ORCID: https://orcid.org/0000-0002-1710-1794; Mayer, Jiri; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690 und Brioli, Annamaria ORCID: https://orcid.org/0000-0002-4072-7592
(2026):
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.
In: Leukemia, Vol. 40: pp. 751-758
[PDF, 1MB]
Knabe, Ricarda; Muller, Philippe ORCID: https://orcid.org/0009-0000-0985-7666; Schliemann, Christoph ORCID: https://orcid.org/0000-0003-1755-9583; Hanoun, Maher ORCID: https://orcid.org/0000-0002-1754-8940; Unglaub, Julia Marie ORCID: https://orcid.org/0000-0002-3577-5493; Weinbergerová, Barbora ORCID: https://orcid.org/0000-0001-6460-2471; Mayer, Jiří; Krekeler, Carolin ORCID: https://orcid.org/0009-0000-1808-5928; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Kaufmann, Martin; Kraus, Sabrina ORCID: https://orcid.org/0000-0001-8954-4220; Steffen, Björn; Modemann, Franziska ORCID: https://orcid.org/0000-0002-5897-3310; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Rudelius, Martina ORCID: https://orcid.org/0000-0001-6928-9955; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Gutmair, Katja ORCID: https://orcid.org/0009-0002-3948-6186; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Herold, Tobias ORCID: https://orcid.org/0000-0002-9615-9432; Röllig, Christoph ORCID: https://orcid.org/0000-0002-3791-0548 und Spiekermann, Karsten ORCID: https://orcid.org/0000-0002-5139-4957
(2025):
Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.
In: Blood Advances, Vol. 9, No. 13: pp. 3336-3339
[PDF, 1MB]
ORCID: https://orcid.org/0009-0000-0985-7666; Schliemann, Christoph ORCID: https://orcid.org/0000-0003-1755-9583; Hanoun, Maher ORCID: https://orcid.org/0000-0002-1754-8940; Unglaub, Julia Marie ORCID: https://orcid.org/0000-0002-3577-5493; Weinbergerová, Barbora ORCID: https://orcid.org/0000-0001-6460-2471; Mayer, Jiří; Krekeler, Carolin ORCID: https://orcid.org/0009-0000-1808-5928; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Kaufmann, Martin; Kraus, Sabrina ORCID: https://orcid.org/0000-0001-8954-4220; Steffen, Björn; Modemann, Franziska ORCID: https://orcid.org/0000-0002-5897-3310; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Rudelius, Martina ORCID: https://orcid.org/0000-0001-6928-9955; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Gutmair, Katja ORCID: https://orcid.org/0009-0002-3948-6186; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Herold, Tobias ORCID: https://orcid.org/0000-0002-9615-9432; Röllig, Christoph ORCID: https://orcid.org/0000-0002-3791-0548 und Spiekermann, Karsten ORCID: https://orcid.org/0000-0002-5139-4957
(2025):
Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.
In: Blood Advances, Vol. 9, No. 13: pp. 3336-3339
[PDF, 1MB]
Schönfeld, Lioba; Rinke, Jenny; Hinze, Anna; Nagel, Saskia N.; Schäfer, Vivien; Schenk, Thomas; Fabisch, Christian; Brümmendorf, Tim H. ORCID: https://orcid.org/0000-0002-9677-3723; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Coutre, Philipp le; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Safizadeh, Fatemeh; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X
(2022):
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia.
In: Leukemia, Vol. 36: pp. 2242-2249
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-9677-3723; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Coutre, Philipp le; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Safizadeh, Fatemeh; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X
(2022):
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia.
In: Leukemia, Vol. 36: pp. 2242-2249
[PDF, 1MB]
Middeke, Jan M.; Metzeler, Klaus H.; Roellig, Christoph; Kraemer, Michael; Eckardt, Jan-Niklas; Stasik, Sebastian; Greif, Philipp A.; Spiekermann, Karsten; Rothenberg-Thurley, Maja; Krug, Utz; Braess, Jan; Kraemer, Alwin; Hochhaus, Andreas; Bruemmendorf, Tim H.; Naumann, Ralph; Steffen, Bjoern; Einsele, Hermann; Schaich, Markus; Burchert, Andreas; Neubauer, Andreas; Goerlich, Dennis; Sauerland, Cristina; Schaefer-Eckart, Kerstin; Schliemann, Christoph; Krause, Stefan W.; Haenel, Mathias; Frickhofen, Norbert; Noppeney, Richard; Kaiser, Ulrich; Kaufmann, Martin; Kunadt, Desiree; Woermann, Bernhard; Sockel, Katja; Bonin, Malte von; Herold, Tobias; Mueller-Tidow, Carsten; Platzbecker, Uwe; Berdel, Wolfgang E.; Serve, Hubert; Baldus, Claudia D.; Ehninger, Gerhard; Schetelig, Johannes; Hiddemann, Wolfgang; Bornhaeuser, Martin; Stoelzel, Friedrich und Thiede, Christian
(2022):
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study.
In: Blood Advances, Vol. 6, No. 5: pp. 1394-1405
Kunadt, Desiree; Stasik, Sebastian; Metzeler, Klaus H.; Roellig, Christoph; Schliemann, Christoph; Greif, Philipp A.; Spiekermann, Karsten; Rothenberg-Thurley, Maja; Krug, Utz; Braess, Jan; Kraemer, Alwin; Hochhaus, Andreas; Scholl, Sebastian; Hilgendorf, Inken; Bruemmendorf, Tim H.; Jost, Edgar; Steffen, Bjoern; Bug, Gesine; Einsele, Hermann; Goerlich, Dennis; Sauerland, Cristina; Schaefer-Eckart, Kerstin; Krause, Stefan W.; Haenel, Mathias; Hanoun, Maher; Kaufmann, Martin; Woermann, Bernhard; Kramer, Michael; Sockel, Katja; Egger-Heidrich, Katharina; Herold, Tobias; Ehninger, Gerhard; Burchert, Andreas; Platzbecker, Uwe; Berdel, Wolfgang E.; Mueller-Tidow, Carsten; Hiddemann, Wolfgang; Serve, Hubert; Stelljes, Matthias; Baldus, Claudia D.; Neubauer, Andreas; Schetelig, Johannes; Thiede, Christian; Bornhaeuser, Martin; Middeke, Jan M. und Stoelzel, Friedrich
(2022):
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
In: Journal of Hematology & Oncology, Vol. 15, No. 1, 126
Röhnert, Maximilian A.; Kramer, Michael; Schadt, Jonas; Ensel, Philipp; Thiede, Christian; Krause, Stefan W.; Bücklein, Veit; Hoffmann, Jörg; Jaramillo, Sonia; Schlenk, Richard F.; Röllig, Christoph; Bornhäuser, Martin; McCarthy, Nicholas; Freeman, Sylvie; Oelschlägel, Uta und Bonin, Malte von
(2022):
Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia.
In: Leukemia, Vol. 36, No. 9: pp. 2208-2217
Kayser, Sabine; Schlenk, Richard F.; Lebon, Delphine; Carre, Martin; Goetze, Katharina S.; Stoelzel, Friedrich; Berceanu, Ana; Schaefer-Eckart, Kerstin; Peterlin, Pierre; Hicheri, Yosr; Rahme, Ramy; Raffoux, Emmanuel; Chermat, Fatiha; Krause, Stefan W.; Aulitzky, Walter E.; Rigaudeau, Sophie; Noppeney, Richard; Berthon, Celine; Goerner, Martin; Jost, Edgar; Carassou, Philippe; Keller, Ulrich; Orvain, Corentin; Braun, Thorsten; Saillard, Colombe; Arar, Ali; Kunzmann, Volker; Wemeau, Mathieu; de Wit, Maike; Niemann, Dirk; Bonmati, Caroline; Schwaenen, Carsten; Abraham, Julie; Aljijakli, Ahmad; Haiat, Stephanie; Kraemer, Alwin; Reichle, Albrecht; Gnadler, Martina; Willekens, Christophe; Spiekermann, Karsten; Hiddemann, Wolfgang; Mueller-Tidow, Carsten; Thiede, Christian; Roellig, Christoph; Serve, Hubert; Bornhaeuser, Martin; Baldus, Claudia D.; Lengfelder, Eva; Fenaux, Pierre; Platzbecker, Uwe und Ades, Lionel
(2021):
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative.
In: Haematologica, Vol. 106, No. 12: pp. 3100-3106
Rautenberg, Christina; Stoelzel, Friedrich; Roellig, Christoph; Stelljes, Matthias; Gaidzik, Verena; Lauseker, Michael; Kriege, Oliver; Verbeek, Mareike; Unglaub, Julia Marie; Thol, Felicitas; Krause, Stefan W.; Haenel, Mathias; Neuerburg, Charlotte; Vucinic, Vladan; Jehn, Christian-Friedrich; Severmann, Julia; Wass, Maxi; Fransecky, Lars; Chemnitz, Jens; Holtick, Udo; Schaefer-Eckart, Kerstin; Schroeder, Josephine; Kraus, Sabrina; Krueger, William; Kaiser, Ulrich; Scholl, Sebastian; Koch, Kathrin; Henning, Lea; Kobbe, Guido; Haas, Rainer; Alakel, Nael; Roehnert, Maximilian-Alexander; Sockel, Katja; Hanoun, Maher; Platzbecker, Uwe; Holderried, Tobias A. W.; Morgner, Anke; Heuser, Michael; Sauer, Tim; Goetze, Katharina S.; Wagner-Drouet, Eva; Doehner, Konstanze; Doehner, Hartmut; Schliemann, Christoph; Schetelig, Johannes; Bornhaeuser, Martin; Germing, Ulrich; Schroeder, Thomas und Middeke, Jan Moritz
(2021):
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
In: Blood Cancer Journal, Vol. 11, No. 10, 164
Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W.; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M.; Heim, Dominik; Brümmendorf, Alice and Haferlach und Pfirrmann, Markus
(2019):
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
In: Haematologica, Vol. 104, No. 5: pp. 955-962
Saussele, Susanne; Hehlmann, Rüdiger; Fabarius, Alice; Jeromin, Sabine; Proetel, Ulrike; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Einsele, Hermann; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Oppliger Leibundgut, Elisabeth; Heim, Dominik; Krause, Stefan W.; Hofmann, Wolf-Karsten; Hasford, Joerg; Pfirrmann, Markus; Müller, Martin C.; Hochhaus, Andreas und Lauseker, Michael
(2018):
Defining therapy goals for major molecular remission in chronic myeloid leukemia: Results of the randomized CML Study IV.
In: Leukemia, Vol. 32, No. 5: pp. 1222-1228
[PDF, 599kB]
Mellinghoff, Sibylle C.; Panse, Jens; Alakel, Nael; Behre, Gerhard; Buchheidt, Dieter; Christopeit, Maximilian; Hasenkamp, Justin; Kiehl, Michael; Koldehoff, Michael; Krause, Stefan W.; Lehners, Nicola; Lilienfeld-Toal, Marie von; Löhnert, Annika Y.; Maschmeyer, Georg; Teschner, Daniel; Ullmann, Andrew J.; Penack, Olaf; Ruhnke, Markus; Mayer, Karin; Ostermann, Helmut; Wolf, Hans-H. und Cornely, Oliver A.
(2018):
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
In: Annals of Hematology, Vol. 97, No. 2: pp. 197-207
Strech, Daniel; Deh, Uwe; Schmitz, Stephan; Gürkan, Irmtraut; Ostermann, Helmut und Krause, Stefan W.
(2015):
Workshop - ökonomische Steuerungsmechanismen: Beispiel Hämatologie und Onkologie.
In: Oncology Research and Treatment, Vol. 38, No. Suppl 1: pp. 3-22
[PDF, 2MB]
Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C.; Hanfstein, Benjamin; Krause, Stefan W.; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M.; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; Pfirrmann, Markus; Hochhaus, Andreas; Hasford, Joerg; Hehlmann, Rüdiger und Saußele, Susanne
(July 2014):
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
In: Annals of Hematology, Vol. 93, No. 7: pp. 1167-1176
[PDF, 985kB]
Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Rüdiger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W.; Schubert, Joerg; Einsele, Hermann; Hänel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Pfirrmann, Markus; Hasford, Jörg; Hofmann, Wolf-Karsten; Hochhaus, Andreas und Müller, Martin C.
(2014):
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib.
In: Haematologica, Vol. 99, No. 9: pp. 1441-1447
[PDF, 784kB]